HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Breakthroughs in Treatments for Idiopathic Pulmonary Fibrosis

With the approval of two new drugs for the treatment of IPF, patients who otherwise would have only had lung transplantation as a treatment option now have a new way to improve their quality of life.

With the approval of two new drugs for the treatment of IPF, patients who otherwise would have only had lung transplantation as a treatment option now have a new way to improve their quality of life.

At the 2014 annual meeting of the American College of Chest Physicians in Austin, TX, the drug approvals were a topic of considerable discussion. Steven Nathan, MD, FCCP, discusses some of the advances made and what work remains to help patients with this complex, hard-to-treat condition.